Larry Lo Selected Research

ziltivekimab

1/2021	Ziltivekimab for Treatment of Anemia of Inflammation in Patients on Hemodialysis: Results from a Phase 1/2 Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.
1/2021	A Phase 1 Randomized Dose-Escalation Study of a Human Monoclonal Antibody to IL-6 in CKD.
1/2021	IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Larry Lo Research Topics

Disease

4	Inflammation (Inflammations) 01/2021 - 04/2019
3	Neoplasms (Cancer) 01/2022 - 06/2008
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 01/2020
2	Chronic Renal Insufficiency 01/2021 - 04/2019
1	Cerebrospinal Fluid Leak 01/2022
1	Wound Infection (Wound Infections) 01/2022
1	Injection Site Reaction 01/2021
1	Anemia 01/2021
1	Neutropenia 01/2021
1	Thrombocytopenia (Thrombopenia) 01/2021
1	Thrombosis (Thrombus) 01/2021
1	Atherosclerosis 01/2021
1	Hypertriglyceridemia 01/2020
1	Chronic Kidney Failure (Chronic Renal Failure) 04/2019
1	Bacteremia 07/2009
1	Anthrax 07/2009
1	Body Weight (Weight, Body) 07/2009
1	Disease Progression 07/2008
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2008
1	Fatigue 06/2008
1	Hypotension (Low Blood Pressure) 06/2008
1	Nausea 06/2008
1	Fever (Fevers) 06/2008

Drug/Important Bio-Agent (IBA)

3	Monoclonal AntibodiesIBA 01/2021 - 06/2008
3	ziltivekimabIBA 01/2021 - 01/2021
3	Interleukin-6 (Interleukin 6)IBA 01/2021 - 01/2021
2	LigandsIBA 01/2021 - 06/2008
2	Pharmaceutical PreparationsIBA 01/2021 - 01/2020
2	mapatumumabIBA 07/2008 - 06/2008
1	HematinicsIBA 01/2021
1	AntibodiesIBA 01/2021
1	C-Reactive ProteinIBA 01/2021
1	CholesterolIBA 01/2021
1	IronIBA 01/2021
1	HDL CholesterolIBA 01/2021
1	Serum AlbuminIBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	HepcidinsIBA 01/2021
1	Ferritins (Ferritin)IBA 04/2019
1	raxibacumabIBA 07/2009
1	AntigensIBA 07/2009
1	PlatinumIBA 07/2008
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2008

Therapy/Procedure

2	Renal Dialysis (Hemodialysis) 01/2021 - 04/2019
1	Length of Stay 01/2022
1	Operative Time 01/2022
1	Therapeutics 01/2021